Literature DB >> 15030889

Simple, rapid determination of enrofloxacin and ciprofloxacin in bovine milk and plasma by high-performance liquid chromatography with fluorescence detection.

Olutosin R Idowu1, James O Peggins.   

Abstract

A rapid and simple procedure for determination of enrofloxacin and ciprofloxacin in bovine milk and plasma is described. Protein precipitation from both milk and plasma samples was achieved by addition of acetonitrile and phosphoric acid. Acetonitrile was removed with methylene chloride, leaving enrofloxacin and ciprofloxacin in the acidic aqueous extract. The aqueous extract was analyzed by high-performance liquid chromatography (HPLC) with fluorescence detection. The limit of quantitation (LOQ) for enrofloxacin and ciprofloxacin in milk was found to be 2ng/ml. LOQ for enrofloxacin and ciprofloxacin in plasma was found to be 1ng/ml. Linear calibration curves were obtained with correlation coefficient (r(2)) >/=0.99. Analysis of quality control (QC) samples gave results within +/-10% of the nominal values. Inter-assay precision for the analysis of milk QC samples were in the ranges: 4.63-12.49% (for enrofloxacin) and 4.67-9.86% (for ciprofloxacin). Inter-assay precision for the analysis of plasma QC samples were in the ranges: 6.60-17.31% (for enrofloxacin) and 6.14-13.87% (for ciprofloxacin). Intra-assay precision for the analysis of milk QC samples were in the following ranges: 3.65-7.21% (for enrofloxacin) and 1.58-14.28% (for ciprofloxacin). Intra-assay precision for the analysis of plasma QC samples were in the following ranges: 2.17-16.95% (for enrofloxacin) and 3.31-16.31% (for ciprofloxacin). The effectiveness of protein precipitants other than phosphoric acid was investigated. The method described has been applied to a study of the pharmacokinetics of enrofloxacin and ciprofloxacin in lactating dairy cows and beef steers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15030889     DOI: 10.1016/j.jpba.2004.01.006

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  13 in total

1.  Resolution of ofloxacin-ciprofloxacin and ofloxacin-norfloxacin binary mixtures by flow-injection chemiluminescence in combination with partial least squares multivariate calibration.

Authors:  J A Murillo; A Alañón Molina; A Muñoz de la Peña; I Durán Merás; A Jiménez Girón
Journal:  J Fluoresc       Date:  2007-06-19       Impact factor: 2.217

2.  Utilization of theoretical studies of the imprinting ratio to guide experimental research into the molecular imprinted polymers formed using enrofloxacin and methacrylic acid.

Authors:  Junbo Liu; Zhengqiang Dai; Bo Li; Shanshan Tang; Ruifa Jin
Journal:  J Mol Model       Date:  2014-09-18       Impact factor: 1.810

3.  Simultaneous determination of malachite green, enrofloxacin and ciprofloxacin in fish farming water and fish feed by liquid chromatography with solid-phase extraction.

Authors:  Hanwen Sun; Lixin Wang; Xiaolan Qin; Xusheng Ge
Journal:  Environ Monit Assess       Date:  2010-10-22       Impact factor: 2.513

Review 4.  From Small Molecules Toward Whole Cells Detection: Application of Electrochemical Aptasensors in Modern Medical Diagnostics.

Authors:  Robert Ziółkowski; Marta Jarczewska; Łukasz Górski; Elżbieta Malinowska
Journal:  Sensors (Basel)       Date:  2021-01-21       Impact factor: 3.576

5.  Simultaneous Determination of Nine Quinolones in Pure Milk Using PFSPE-HPLC-MS/MS with PS-PAN Nanofibers as a Sorbent.

Authors:  Lanlan Wei; Yanan Chen; Dongliang Shao; Jingjun Li
Journal:  Foods       Date:  2022-06-22

6.  Efficacy of enrofloxacin in a mouse model of sepsis.

Authors:  Andrea R Slate; Sheila Bandyopadhyay; Kevin P Francis; Mark G Papich; Brian Karolewski; Eldad A Hod; Kevin A Prestia
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-07       Impact factor: 1.232

7.  Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition.

Authors:  Simon N Muchohi; Nahashon Thuo; Japhet Karisa; Alex Muturi; Gilbert O Kokwaro; Kathryn Maitland
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-12-04       Impact factor: 3.205

8.  Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Enrofloxacin and Its Degradation Products in Tablet Dosage Forms.

Authors:  V Ashok Chakravarthy; B B V Sailaja; Avvaru Praveen Kumar
Journal:  J Anal Methods Chem       Date:  2015-01-29       Impact factor: 2.193

9.  Age-related P-glycoprotein expression in the intestine and affecting the pharmacokinetics of orally administered enrofloxacin in broilers.

Authors:  Mengjie Guo; Shamsuddin Bughio; Yong Sun; Yu Zhang; Lingling Dong; Xiaohua Dai; Liping Wang
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

10.  E. coli infection modulates the pharmacokinetics of oral enrofloxacin by targeting P-glycoprotein in small intestine and CYP450 3A in liver and kidney of broilers.

Authors:  Mengjie Guo; Yong Sun; Yu Zhang; Shamsuddin Bughio; Xiaohua Dai; Weilong Ren; Liping Wang
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.